Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 301.68 Million

CAGR (2025-2030)

4.81%

Fastest Growing Segment

Direct

Largest Market

     North America

Market Size (2030)

USD 447.60 Million

Market Overview

Global Vitamin B1 Market was valued at USD 301.68 Million in 2024 and is expected to reach USD 447.60 Million by 2030 with a CAGR of 4.81%. Vitamin B1 is an essential water-soluble vitamin that plays a critical role in carbohydrate metabolism and nervous system function. Its importance in human and animal health has positioned it as a vital ingredient across multiple industries. In the animal nutrition industry, Vitamin B1 is increasingly incorporated into livestock and aquaculture feed to promote healthy growth and enhance metabolic function. With rising global meat consumption and an emphasis on animal health, the demand for vitamin-fortified feed is expected to remain strong, particularly in emerging markets across Asia Pacific and North America.

Despite positive growth prospects, the market faces several challenges, including fluctuations in raw material availability and price volatility, which can impact production costs. Additionally, regulatory scrutiny and quality control issues in some manufacturing regions may pose risks to product integrity and supply chain reliability. Moreover, the presence of counterfeit or substandard products in some markets can undermine consumer trust and hamper overall market development.

Key Market Drivers

Growth in Pharmaceutical Industry

The global Vitamin B1 (thiamine) market is experiencing sustained growth, largely driven by the rapid expansion of the pharmaceutical industry. The global pharmaceutical industry has witnessed substantial growth over the past two decades, generating approximately USD 1.6 trillion in revenue in 2023. This level of expansion has positioned the industry's market size on par with the gross domestic products (GDPs) of nations such as Spain, Mexico, and Australia. As a critical water-soluble vitamin involved in carbohydrate metabolism, nerve function, and energy production, Vitamin B1 holds significant therapeutic value across a range of clinical applications. The increasing prevalence of vitamin deficiencies, lifestyle-related disorders, and chronic illnesses has led to a growing demand for pharmaceutical-grade thiamine formulations, thereby fueling market expansion.

Pharmaceutical companies are increasingly incorporating Vitamin B1 into a broad spectrum of products, including multivitamin tablets, nutritional supplements, and injectable solutions, to address both preventive and therapeutic health needs. In 2023, Lupin announced the commercial launch of Thiamine Hydrochloride Injection USP, 200 mg/2 mL (100 mg/mL) in multiple-dose vials, following the approval of the Abbreviated New Drug Application (ANDA) by the U.S. Food and Drug Administration (FDA) for its alliance partner, Caplin Steriles Limited (Caplin). Thiamine is commonly prescribed to treat conditions such as beriberi, Wernicke-Korsakoff syndrome, and peripheral neuropathy, particularly among diabetic and alcohol-dependent patient populations. As awareness of these conditions rises, demand for thiamine-based interventions continues to grow.

Growth in Food Additives Industry

The rapid expansion of the food additives industry has emerged as a key driver of the global Vitamin B1 (thiamine) market. Similar to other B-complex vitamins, thiamine is often referred to as an "anti-stress" vitamin due to its potential to support immune function and enhance the body's resilience to stress. Designated as vitamin B1 being the first B vitamin identified thiamine is present in both plant and animal sources and plays an essential role in key metabolic processes. As the demand for fortified, functional, and processed foods continues to grow, Vitamin B1 is increasingly incorporated as a nutritional additive to enhance the health profile of a wide range of food and beverage products.

Vitamin B1 plays a vital role in energy metabolism, nervous system function, and carbohydrate digestion. Its essential health benefits make it a preferred additive in the formulation of fortified cereals, energy drinks, dietary supplements, and infant nutrition products. With rising health awareness among consumers and a growing emphasis on preventive healthcare, food manufacturers are under pressure to offer products that not only satisfy taste preferences but also deliver nutritional value creating a sustained demand for thiamine-based additives.


Download Free Sample Report

Key Market Challenges

High Cost of Thiamine Mononitrate

The high cost of thiamine mononitrate presents a significant challenge to the growth and competitiveness of the global Vitamin B1 market. Thiamine mononitrate, a stable and widely used synthetic form of Vitamin B1, is commonly incorporated into dietary supplements, fortified foods, and pharmaceutical formulations due to its superior shelf life and bioavailability. However, its relatively high production cost often results in elevated pricing, which can limit its adoption particularly in cost-sensitive markets.

Several factors contribute to the high cost structure of thiamine mononitrate. The manufacturing process is chemically intensive and requires stringent quality control to meet regulatory standards for pharmaceutical and food-grade applications. Fluctuations in the price and availability of key raw materials, such as coal tar derivatives and intermediates used in synthesis, can further drive up production costs. In addition, energy consumption, waste management, and compliance with environmental and safety regulations add to the operational burden for producers, especially in regions with stricter regulatory environments.

Key Market Trends

Rising Demand of Vitamin B1 from the Animal Nutrition Segment

The animal nutrition segment is emerging as a significant growth driver in the global Vitamin B1 (thiamine) market. Specifically, India’s population and income levels are projected to grow steadily through 2050, which is likely to drive increased domestic demand for animal-based food products such as meat, dairy, and eggs. Increasing awareness about the nutritional benefits of Vitamin B1 in livestock and poultry feed formulations is propelling demand, as producers strive to enhance animal health, productivity, and overall feed efficiency.

Vitamin B1 plays a vital role in carbohydrate metabolism and nervous system function, making it essential for maintaining optimal growth and preventing deficiency-related disorders in animals. Livestock farmers and feed manufacturers are increasingly incorporating Vitamin B1 into feed additives to improve digestion, boost immunity, and reduce the risk of metabolic diseases, which can otherwise impact productivity and profitability.

Segmental Insights

Sales Channel Insights

Based on Sales Channel, Direct have emerged as the fastest growing segment in the Global Vitamin B1 Market in 2024. One key driver is the growing preference among manufacturers for direct procurement of Vitamin B1 to ensure better quality control, cost efficiency, and supply chain transparency. By sourcing Vitamin B1 directly, companies can tailor formulations to specific product requirements and maintain consistent nutrient content, which is critical for regulatory compliance and consumer trust.

End Use Insights

Based on End Use, Dairy Products have emerged as the fastest growing segment in the Global Vitamin B1 Market during the forecast period. Rising awareness about the role of Vitamin B1 in energy metabolism, nerve function, and overall well-being has driven manufacturers to innovate and expand fortified dairy product lines. This trend is particularly strong among health-conscious consumers and parents seeking to improve the nutritional intake of children.


Download Free Sample Report

Regional Insights

Based on Region, North America have emerged as the dominating region in the Global Vitamin B1 Market in 2024. The region benefits significantly from a well-established and advanced healthcare infrastructure that facilitates easy access to medical services and nutritional products. Moreover, there is a high level of consumer awareness and education regarding the importance of nutritional supplements, which has led to increased demand. This demand is further fueled by a growing emphasis on preventive healthcare and overall wellness, as consumers increasingly prioritize maintaining health and avoiding illness. In addition, the rising prevalence of lifestyle-related health conditions, such as diabetes and cardiovascular diseases, has created a greater need for vitamin B1 supplementation. Strong investments in research and development by key industry players have also driven innovation and product availability, collectively contributing to sustained market expansion in the region.

Recent Development

  • In April 2025, chemists validated a 67-year-old hypothesis regarding vitamin B1 by successfully stabilizing a reactive molecule in water an achievement previously considered unattainable. This breakthrough not only resolves a longstanding biochemical enigma but also paves the way for more sustainable and efficient pharmaceutical manufacturing methods. The molecule involved is a carbene, a carbon atom characterized by having only six valence electrons instead of the typical eight, rendering it chemically unstable and highly reactive. Normally, carbenes decompose immediately in water. However, scientists have long theorized that vitamin B1, or thiamine, may form a carbene-like structure within human cells to facilitate essential biochemical reactions. For the first time, researchers have generated a stable carbene in aqueous conditions, successfully isolated it, and preserved it in a sealed container, where it remained stable for several months.
  • In May 2024, ProBiotix Health Plc introduced InstaMelt, an innovative food supplement designed to provide health brands and retailers with a comprehensive turnkey solution for rebranding. The InstaMelt formulation combines two science-backed, natural ingredients, including the company’s proprietary ingredient LPLDL, a patented probiotic strain demonstrated through multiple independent human intervention studies to significantly reduce LDL cholesterol and elevate HDL levels and Thiamine (Vitamin B1), which supports cardiovascular health.
  • In February 2025, ACI Pure Flour Limited introduced a new fortified flour product, "ACI Pure Power Flour," at the Shwapno outlet in Gulshan-1, Dhaka. This product aims to address nutritional deficiencies in the daily diet by being enriched with 10 essential vitamins and minerals, including folic acid, zinc, calcium, iron, and vitamins A, B1, B2, B3, B6, and B12. By enhancing the nutritional value of everyday meals, this fortified flour supports healthier living. Shwapno remains dedicated to offering health-focused products to consumers, and the launch of ACI Pure Fortified Atta aligns with and reinforces that commitment.
  • In February 2024, Otsuka Pharmaceutical Factory, Inc. announced an enhancement to its concentrated liquid diet product, “Hine Jelly,” featuring improved formulation and physical properties. The company will also introduce “HINEX Jelly” as a new addition to the existing “HINEX” line of concentrated liquid diet products. This semisolid, jelly-type product is formulated with agar and designed for individuals requiring a daily caloric intake between 900 and 1500 kcal. Aligned with the Dietary Reference Intakes for Japanese (2020), the product provides a balanced composition of the three major nutrients, along with essential vitamins such as Vitamin A and key minerals.

Key Market Players

  • HUAZHONG PHARMACEUTICAL CO., LTD.
  • Brother Enterprises Holding Co.
  • Jiangxi Tianxin Pharmaceutical Co., Ltd
  • dsm-firmenich
  • Medikonda Nutrients

By Sales Channel

By End Use

By Region

  • Direct
  • Indirect
  • Pharmaceutical
  • Feed Additives
  • Food Additives
  • Dairy Products
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope

In this report, the Global Vitamin B1 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Vitamin B1 Market, By Sales Channel:

o   Direct

o   Indirect

  • Vitamin B1 Market, By End Use:

o   Pharmaceutical

o   Feed Additives

o   Food Additives

o   Dairy Products

o   Others

  • Vitamin B1 Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B1 Market.

Available Customizations:

Global Vitamin B1 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Vitamin B1 Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, and Trends

4.    Impact of COVID-19 on Global Vitamin B1 Market

5.    Global Vitamin B1 Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Sales Channel (Direct, Indirect)

5.2.2.     By End Use (Pharmaceutical, Feed Additives, Food Additives, Dairy Products, Others)

5.2.3.     By Region

5.2.4.     By Company (2024) 

5.3.  Market Map

6.    North America Vitamin B1 Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Sales Channel

6.2.2.     By End Use

6.2.3.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Vitamin B1 Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Sales Channel

6.3.1.2.2.             By End Use

6.3.2.     Mexico Vitamin B1 Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Sales Channel

6.3.2.2.2.             By End Use

6.3.3.     Canada Vitamin B1 Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Sales Channel

6.3.3.2.2.             By End Use

7.    Europe Vitamin B1 Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Sales Channel

7.2.2.     By End Use

7.2.3.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Vitamin B1 Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Sales Channel

7.3.1.2.2.             By End Use

7.3.2.     Germany Vitamin B1 Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Sales Channel

7.3.2.2.2.             By End Use

7.3.3.     United Kingdom Vitamin B1 Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Sales Channel

7.3.3.2.2.             By End Use

7.3.4.     Italy Vitamin B1 Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Sales Channel

7.3.4.2.2.             By End Use

7.3.5.     Spain Vitamin B1 Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Sales Channel

7.3.5.2.2.             By End Use

8.    Asia Pacific Vitamin B1 Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Sales Channel

8.2.2.     By End Use

8.2.3.     By Country

8.3.  Asia Pacific: Country Analysis

8.3.1.     China Vitamin B1 Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Sales Channel

8.3.1.2.2.             By End Use

8.3.2.     India Vitamin B1 Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Sales Channel

8.3.2.2.2.             By End Use

8.3.3.     South Korea Vitamin B1 Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Sales Channel

8.3.3.2.2.             By End Use

8.3.4.     Japan Vitamin B1 Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Sales Channel

8.3.4.2.2.             By End Use

8.3.5.     Australia Vitamin B1 Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Sales Channel

8.3.5.2.2.             By End Use

9.    South America Vitamin B1 Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Sales Channel

9.2.2.     By End Use

9.2.3.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Vitamin B1 Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Sales Channel

9.3.1.2.2.             By End Use

9.3.2.     Argentina Vitamin B1 Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Sales Channel

9.3.2.2.2.             By End Use

9.3.3.     Colombia Vitamin B1 Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Sales Channel

9.3.3.2.2.             By End Use

10.  Middle East and Africa Vitamin B1 Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Sales Channel

10.2.2.  By End Use

10.2.3.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Vitamin B1 Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Sales Channel

10.3.1.2.2.           By End Use

10.3.2.  Saudi Arabia Vitamin B1 Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Sales Channel

10.3.2.2.2.           By End Use

10.3.3.  UAE Vitamin B1 Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Sales Channel

10.3.3.2.2.           By End Use

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

12.1.              Merger & Acquisition (If Any)

12.2.              Product Launches (If Any)

12.3.              Recent Developments

13.  Global Vitamin B1 Market: SWOT Analysis

14.  Porters Five Forces Analysis

14.1.              Competition in the Industry

14.2.              Potential of New Entrants

14.3.              Power of Suppliers

14.4.              Power of Customers

14.5.              Threat of Substitute Products

15.  Competitive Landscape 

15.1.              HUAZHONG PHARMACEUTICAL CO., LTD.

15.1.1.  Business Overview

15.1.2.  Company Snapshot

15.1.3.  Products & Services

15.1.4.  Financials (As Reported)

15.1.5.  Recent Developments

15.1.6.  Key Personnel Details

15.1.7.  SWOT Analysis

15.2.              Brother Enterprises Holding Co.

15.3.              Jiangxi Tianxin Pharmaceutical Co., Ltd

15.4.              dsm-firmenich

15.5.              Medikonda Nutrients

16.  Strategic Recommendations

17.  About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Vitamin B1 Market was estimated to be USD 301.68 Million in 2024.

The direct segment demonstrated significant growth in 2024. This can be attributed to advancements in production technologies.

North America dominated the market with a revenue share in 2024. This is due to the presence of major market players and efficient distribution channels.

Growth in pharmaceutical and food additives industries are the major drivers for the Global Vitamin B1 Market.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.